Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats

References

• Asharani PV, Hande MP, Valiyaveettil S. 2009a. Anti-proliferative activity of silver nanoparticles. BMC Cell Biology 10:65.
   PubMed Web of Science ®Google Scholar
• Asharani PV, Kah Mun GL, Hande MP, Valiyaveettil S. 2009b. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS-Nano 3:279–290.
   PubMed Web of Science ®Google Scholar
• Asharani PV, Wu YL, Gong Z, Valiyaveettil S. 2008. Toxicity of silver nanoparticles in zebrafish models. Nanotechnolgy 19:255102.
   PubMed Web of Science ®Google Scholar
• Baldi C, Minoia C, Di NA, Capodaglio E, Manzo L. 1988. Effects of silver in isolated rat hepatocytes. Toxicol Lett 41:261–268.
   PubMed Web of Science ®Google Scholar
• Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. 2009. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 5:1897–1910.
   PubMed Web of Science ®Google Scholar
• Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, Surprenant A, Lopez-Castejon G, Mann S, Davis SA, Hails LA, Ingham E, Verkade P, Lane J, Heesom K, Newson R, Case PC. 2009. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotech 4:876–883.
   PubMed Web of Science ®Google Scholar
• Bradford MM. 1976. A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254.
   PubMed Web of Science ®Google Scholar
• Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC. 2005. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88:412–419.
   PubMed Web of Science ®Google Scholar
• Brown JS, Zeman KL, Bennett WD. 2002. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med 166:1240–1247.
   PubMed Web of Science ®Google Scholar
• Castillo PM, Herrera JL, Fernandez-Montesinos R, Caro C, Zaderenko AP, Mejias JA, Pozo D. 2008. Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands. Nanomed 3:627–635.
   PubMed Web of Science ®Google Scholar
• Chen J, Han CM, Lin XW, Tang ZJ, Su SJ. 2006. Effect of silver nanoparticle dressing on second degree burn wound. Zhonghua Wai Ke Za Zhi 44:50–52.
   PubMedGoogle Scholar
• Chithrani BD, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–668.
   PubMed Web of Science ®Google Scholar
• Colvin VL. 2003. The potential environmental impact of engineered nanomaterials. Nat Biotechnol 21:1166–1170.
   PubMed Web of Science ®Google Scholar
• Damm C, Munstedt H. 2008. Kinetic aspects of the silver ion release from antimicrobial polyamide/silver nanocomposites. Appl Phys A 91:479–486.
   Web of Science ®Google Scholar
• Duffin R, Tran L, Brown D, Stone V, Donaldson K. 2007. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 19:849–856.
   PubMed Web of Science ®Google Scholar
• Gan X, Liu T, Zhong J, Liu X, Li G.2004. Effect of silver nanoparticles on the electron transfer reactivity and the catalytic activity of myoglobin. Chem Bio Chem 5:1686–1691.
   Google Scholar
• Gogoi SK, Gopinath P, Paul A, Ramesh A, Ghosh SS, Chattopadhyay A. 2006. Green fluorescent protein expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles. Langmuir 22:9322–9328.
   PubMed Web of Science ®Google Scholar
• Gopinath P, Gogoi SK, Chattopadhyay A, Ghosh SS. 2008. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. Nanotechnology 19:1–10.
   PubMed Web of Science ®Google Scholar
• Gopinath P, Gogoi SK, Sanpui P, Paul, A. Chattopadhyay, Arun., Ghosh SS. 2010. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloid Surf B Biointerfaces 77:240–245.
   PubMed Web of Science ®Google Scholar
• Gwinn MR, Vallyathan V. 2006. Nanoparticles: health effects – pros and cons. Environ Health Perspect 114:1818–1825.
   PubMed Web of Science ®Google Scholar
• Hayashi I, Morishita Y, Imai K, Nakamura M, Nakachi K, Hayashi T. 2007. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mut Res 631:55–61.
   PubMed Web of Science ®Google Scholar
• Holt KB, Bard AJ. 2005. Interaction of silver(I) ions with the respiratory chain of Escherichia coli: an electrochemical and scanning electrochemical microscopic study of the antimicrobial mechanism of micromolar Ag+. Biochemistry 44:13214–13223.
   PubMed Web of Science ®Google Scholar
• Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19:975–983.
   PubMed Web of Science ®Google Scholar
• Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han BS, Shin JH, Sung, JH, Song KS, Yu IJ. 2007. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 19:857–871.
   PubMed Web of Science ®Google Scholar
• Jin CY, Zhu BS, Wang XF, Lu QH. 2008a. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem Res Toxicol 21:1871–1877.
   PubMed Web of Science ®Google Scholar
• Jin T, Fujii F, Komai Y, Seki J, Seiyama A, Yoshioka Y. 2008b. Preparation and characterizationof highly fluorescent, glutathione-coated near infrared quantum dots for in vivo fluorescence imaging. Int J Mol Sci 9:2044–2061.
   PubMed Web of Science ®Google Scholar
• Jin T, Yoshioka Y, Fujii F, Komai Y, Seki J, Seiyama A. 2008c. Gd3+-functionalized near-infrared quantum dots for in vivo dual modal (fluorescence/magnetic resonance) imaging. Chem Comm 30:5764–5766.
   Google Scholar
• Kawata K, Osawa M, Okabe S. 2009. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 43:6046–6051.
   PubMed Web of Science ®Google Scholar
• Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, Kim SH, Park YK, Park YH, Hwang CY. 2007. Antimicrobial effects of silver nanoparticles. Nanomed 3:95–101.
   PubMed Web of Science ®Google Scholar
• Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY. 2009. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In-Vitro 23:1076–1084.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung YH, Kwon IH, Jeong J, Han BS, Yu IJ. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20:575–583.
   PubMed Web of Science ®Google Scholar
• Kneipp J, Kneipp H, McLaughlin M, Brown D, Kneipp K. 2006. In vivo molecular probing of cellular compartments with gold nanoparticles and nanoaggregates. Nano Lett 6:2225–2231.
   Google Scholar
• Kulmeet KS, Catherine MM, Joseph MS, Sallie WS, Vincent MR. 2002. Gold nanoparticle-mediated transfection of mammalian cells. Bioconjugate Chem 13:3–6.
   PubMedGoogle Scholar
• Liu L, Zhang J, Su X, Mason RP. 2008. In vitro and in vivo assessment of CdTe and CdHgTe toxicity and clearance. J Biomed Nanotechnol 4:524–528.
   PubMedGoogle Scholar
• Loeb WF, Quimby FW, editors. 1999. The clinical chemistry of laboratory animals. Philadelphia, PA: Taylor & Francis.
   Google Scholar
• Lok CN, Ho CM, Chen R, He QY, Yu WY, Sun H, Tam PK, Chiu JF, Che CM. 2006. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 5:916–924.
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311:622–627.
   PubMed Web of Science ®Google Scholar
• Pamela LD, Kyle JH. 2005. Exposure-related health effects of silver and silver compounds: a review. Ann Hyg 49:575–585.
   PubMedGoogle Scholar
• Pandey R, Zahoor A, Sharma S, Khuller GK. 2003. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis (Edinb) 83:373–378.
   PubMed Web of Science ®Google Scholar
• Park JH, Gu L, Maltzahn GV, Ruoslahti E, Bhatia SN, Sailor MJ. 2009. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat Mater 8:331–336.
   PubMed Web of Science ®Google Scholar
• Santoro CM, Duchsherer NL, Grainger DW. 2007. Minimal in vitro antimicrobial efficacy and ocular cell toxicity from silver nanoparticles. Nanobiotech 3:55–65.
   PubMedGoogle Scholar
• Schipper ML, Ratchford NN, Davis CR, Shi Kam NW, Chu P, Liu Z, Sun X, Dai H, Gambhir SS. 2008. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol 3:216–221.
   PubMed Web of Science ®Google Scholar
• Shin SH, Ye MK, Kim HS, Kang HS. 2007. The effects of nanosilver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 7:1813–1818.
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Bera T, Singh SK, Singh G, Ramachandrarao P, Dash D. 2009. Characterization of antiplatelet properties of silver nanoparticles. ACS Nano 6:1357–1364.
   Google Scholar
• Simon-Deckers A, Gouget B, Mayne-L’hermite M, Herlin-Boime N, Reynaud C, Carrière M. 2008. In vitro investigation of oxide nanoparticle and carbon nanotube toxicity and intracellular accumulation in A549 human pneumocytes. Toxicology 253:137–146.
   PubMed Web of Science ®Google Scholar
• Singh AV, Patil R, Kasture MB, Gade WN, Prasad BL. 2009. Synthesis of Ag-Pt alloy nanoparticles in aqueous bovine serum albumin foam and their cytocompatibility against human gingival fibroblasts. Colloid Surf B Biointerfaces 69:239–245.
   PubMedGoogle Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Contr Rel 70:1–20.
   PubMed Web of Science ®Google Scholar
• Sukdeb P, Yu KT, Joon MS. 2007. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712–1720.
   PubMed Web of Science ®Google Scholar
• Sun Y, Xia Y. 2002. Shape-controlled synthesis of gold and silver nanoparticles. Science 298:2176–2179.
   PubMed Web of Science ®Google Scholar
• Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108:452–461.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Yoon JU, Kim DS, Song MY, Jeong J, Han BS, Han JH, Chung YH, Kim J, Kim TS, Chang HK, Lee EJ,Lee JH,Yu, IJ. 2008. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticle. Inhal Toxicol 20:567–574.
   PubMed Web of Science ®Google Scholar
• Susan WP, Wijnhoven JGM, Peijnenburg CAH, Werner IH, Agnes GO, Evelyn HWH, Boris R, Julia B, Ilse G, Dik VM, Susan D, Wim HDJ, Maaike Z, Adriënne JAM, Robert EG. 2009. Nano-silver- a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2:109–138.
   Google Scholar
• Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder J. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ H Perspect 109:547–551.
   PubMed Web of Science ®Google Scholar
• Tiwari DK, Behari J, Sen P. 2008. Time and dose dependent antimicrobial potential of Ag- nanoparticle synthesized by top-down approach. Curr Sci 95:1–10.
   Google Scholar
• Wissing SA, Kayser O, Muller RH. 2004. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56:1257–1272.
   PubMed Web of Science ®Google Scholar
• Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Mark RW, Nel AE. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794–1807.
   PubMed Web of Science ®Google Scholar
• Yu DG. 2007. Formation of colloidal silver nanoparticles stabilized by Na+-poly(gammaglutamic acid)-silver nitrate complex via chemical reduction process. Colloid Surf B Biointerfaces 59:171–178.
   PubMed Web of Science ®Google Scholar
• Zolghadri S, Saboury AA, Golestani A, Divsalar A, Rezaei-Zarchi S, Moosavi-Movahedi AA. 2009. Interaction between silver nanoparticle and bovine hemoglobin at different temperatures. J Nanoparticle Res 11:1751–1758.
   Web of Science ®Google Scholar